Atara Biotherapeutics (ATRA) Other Non Operating Income (2015 - 2025)
Atara Biotherapeutics (ATRA) reported Other Non Operating Income of -$49000.0 for Q4 2025, up 44.94% on a YoY basis from -$33806.2 in Q4 2024, and down 1325.0% quarter-over-quarter from $4000.0 in Q3 2025.
Atara Biotherapeutics (ATRA) Other Non Operating Income (2015 - 2025) Analysis & Trends
Atara Biotherapeutics has reported Other Non Operating Income for 11 years, with the latest figure at -$49000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income rose 44.94% year-over-year to -$49000.0; the trailing twelve-month figure through Mar 2026 stood at -$23000.0 (down 105.12% YoY), and the FY2025 full-year result was -$34000.0, down 106.44% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$49000.0, down from $4000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $555000.0 in Q3 2024, with the low at -$309000.0 in Q3 2022.
- Historically, Other Non Operating Income has averaged -$4300.0 across 5 years, with a median of -$11500.0 in 2023.
- The largest YoY upside for Other Non Operating Income was 2155.56% in 2024 against a maximum downside of 641.67% in 2024.
- Atara Biotherapeutics' Other Non Operating Income stood at $84000.0 in 2021, then plunged by 182.14% to -$69000.0 in 2022, then jumped by 82.61% to -$12000.0 in 2023, then tumbled by 641.67% to -$89000.0 in 2024, then soared by 44.94% to -$49000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$49000.0 (Q4 2025), $4000.0 (Q3 2025), and $22000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Dec 31, 2024 | -89,000.00 |
| Sep 30, 2024 | 555,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | -197,000.00 |
| Dec 31, 2022 | -69,000.00 |
| Sep 30, 2022 | -309,000.00 |
| Jun 30, 2022 | -214,000.00 |
| Mar 31, 2022 | -109,000.00 |
| Dec 31, 2021 | 84,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Jun 30, 2021 | 225,000.00 |
| Mar 31, 2021 | -90,000.00 |